Stocks · Health care · Services-Commercial Physical & Biological Research

ICON PLC

ICLR Clue Score36
Ireland CIK 0001060955
$164.17 -0.20% Close, 9 Oct 2026
Price $164.17 −38.02% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue1.67Operating income0.31Net income0.26EPS, diluted4.65Fiscal year 2017Revenue1.76 +5.5%Operating income0.34Net income0.28 +7.4%EPS, diluted5.13 +10.3%Fiscal year 2018Revenue2.60 +47.6%Operating income0.37Net income0.32 +14.6%EPS, diluted5.89 +14.8%Fiscal year 2019Revenue2.81 +8.1%Operating income0.43Net income0.37 +15.9%EPS, diluted6.79 +15.3%Fiscal year 2020Revenue2.80 −0.3%Operating income0.39Net income0.33 −11.1%EPS, diluted6.15 −9.4%Fiscal year 2021Revenue5.48 +95.9%Operating income0.38Net income0.15 −53.9%EPS, diluted2.25 −63.4%Fiscal year 2022Revenue7.74 +41.2%Operating income0.80Net income0.51 +229.9%EPS, diluted6.13 +172.4%Fiscal year 2023Revenue8.05 +4.1%Operating income0.90Net income0.55 +9.7%EPS, diluted6.70 +9.3%Fiscal year 2024Revenue8.19 +1.7%Operating income1.03Net income0.74 +33.4%EPS, diluted8.90 +32.8%Fiscal year 2025Revenue8.25 +0.8%Operating income0.44Net income0.23 −69.0%EPS, diluted2.90 −67.4%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 1.67 1.76 2.60 2.81 2.80 5.48 7.74 8.05 8.19 8.25
Growth +5.5% +47.6% +8.1% −0.3% +95.9% +41.2% +4.1% +1.7% +0.8%
Operating income 0.31 0.34 0.37 0.43 0.39 0.38 0.80 0.90 1.03 0.44
Net income 0.26 0.28 0.32 0.37 0.33 0.15 0.51 0.55 0.74 0.23
Growth +7.4% +14.6% +15.9% −11.1% −53.9% +229.9% +9.7% +33.4% −69.0%
EPS, diluted 4.65 5.13 5.89 6.79 6.15 2.25 6.13 6.70 8.90 2.90
Growth +10.3% +14.8% +15.3% −9.4% −63.4% +172.4% +9.3% +32.8% −67.4%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin18.7%Net margin15.7%Free cash flow margin13.0%Fiscal year 2017Operating margin19.2%Net margin16.0%Free cash flow margin19.2%Fiscal year 2018Operating margin14.4%Net margin12.4%Free cash flow margin8.5%Fiscal year 2019Operating margin15.4%Net margin13.3%Free cash flow margin13.3%Fiscal year 2020Operating margin14.0%Net margin11.9%Free cash flow margin18.8%Fiscal year 2021Operating margin6.9%Net margin2.8%Free cash flow margin13.4%Fiscal year 2022Operating margin10.3%Net margin6.5%Free cash flow margin5.4%Fiscal year 2023Operating margin11.2%Net margin6.9%Free cash flow margin12.7%Fiscal year 2024Operating margin12.6%Net margin9.0%Free cash flow margin13.7%Fiscal year 2025Operating margin5.4%Net margin2.8%Free cash flow margin10.4%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin 18.7% 19.2% 14.4% 15.4% 14.0% 6.9% 10.3% 11.2% 12.6% 5.4%
Net margin 15.7% 16.0% 12.4% 13.3% 11.9% 2.8% 6.5% 6.9% 9.0% 2.8%
Free cash flow margin 13.0% 19.2% 8.5% 13.3% 18.8% 13.4% 5.4% 12.7% 13.7% 10.4%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow0.26Capital expenditure−0.04Free cash flow0.22Buybacks−0.11Fiscal year 2017Operating cash flow0.38Capital expenditure−0.04Free cash flow0.34 +56.2%Buybacks−0.13Fiscal year 2018Operating cash flow0.27Capital expenditure−0.05Free cash flow0.22 −34.9%Buybacks−0.13Fiscal year 2019Operating cash flow0.41Capital expenditure−0.04Free cash flow0.37 +69.6%Buybacks−0.15Fiscal year 2020Operating cash flow0.57Capital expenditure−0.04Free cash flow0.53 +41.1%Buybacks−0.18Fiscal year 2021Operating cash flow0.83Capital expenditure−0.09Free cash flow0.74 +39.5%Buybacks0.00Fiscal year 2022Operating cash flow0.56Capital expenditure−0.14Free cash flow0.42 −42.7%Buybacks−0.10Fiscal year 2023Operating cash flow1.16Capital expenditure−0.14Free cash flow1.02 +142.3%Buybacks0.00Fiscal year 2024Operating cash flow1.29Capital expenditure−0.17Free cash flow1.12 +9.6%Buybacks−0.50Fiscal year 2025Operating cash flow1.04Capital expenditure−0.17Free cash flow0.86 −22.9%Buybacks−0.75
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 0.26 0.38 0.27 0.41 0.57 0.83 0.56 1.16 1.29 1.04
Capital expenditure −0.04 −0.04 −0.05 −0.04 −0.04 −0.09 −0.14 −0.14 −0.17 −0.17
Free cash flow 0.22 0.34 0.22 0.37 0.53 0.74 0.42 1.02 1.12 0.86
Growth +56.2% −34.9% +69.6% +41.1% +39.5% −42.7% +142.3% +9.6% −22.9%
Buybacks −0.11 −0.13 −0.13 −0.15 −0.18 0.00 −0.10 0.00 −0.50 −0.75

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash0.19Shareholders’ equity0.95Fiscal year 2017Cash0.28Shareholders’ equity1.19Fiscal year 2018Cash0.40Shareholders’ equity1.35Fiscal year 2019Cash0.52Shareholders’ equity1.62Fiscal year 2020Cash0.84Total debt0.35Net cash (debt)0.49Shareholders’ equity1.85Debt to equity0.19Fiscal year 2021Cash0.75Total debt5.38Net cash (debt)−4.63Shareholders’ equity8.07Debt to equity0.67Fiscal year 2022Cash0.29Total debt4.60Net cash (debt)−4.31Shareholders’ equity8.53Debt to equity0.54Fiscal year 2023Cash0.38Total debt3.67Net cash (debt)−3.29Shareholders’ equity9.21Debt to equity0.40Fiscal year 2024Cash0.54Total debt3.40Net cash (debt)−2.86Shareholders’ equity9.44Debt to equity0.36Fiscal year 2025Cash0.65Total debt2.87Net cash (debt)−2.23Shareholders’ equity9.19Debt to equity0.31
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.19 0.28 0.40 0.52 0.84 0.75 0.29 0.38 0.54 0.65
Total debt n/a n/a n/a n/a 0.35 5.38 4.60 3.67 3.40 2.87
Net cash (debt) n/a n/a n/a n/a 0.49 −4.63 −4.31 −3.29 −2.86 −2.23
Shareholders’ equity 0.95 1.19 1.35 1.62 1.85 8.07 8.53 9.21 9.44 9.19
Debt to equity n/a n/a n/a n/a 0.19 0.67 0.54 0.40 0.36 0.31

In billions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In billions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
0.26 0.38 0.27 0.41 0.57 0.83 0.56 1.16 1.29 1.04
Growth +47.8% −29.9% +53.6% +37.7% +46.0% −32.1% +106.1% +10.8% −19.5%
n/a n/a n/a 0.06 0.07 0.31 0.57 0.59 0.49 0.38
Investment
−0.04 −0.04 −0.05 −0.04 −0.04 −0.09 −0.14 −0.14 −0.17 −0.17
calc 0.22 0.34 0.22 0.37 0.53 0.74 0.42 1.02 1.12 0.86
Growth +56.2% −34.9% +69.6% +41.1% +39.5% −42.7% +142.3% +9.6% −22.9%
calc 3.84 6.17 4.02 6.88 9.89 10.80 5.11 12.34 13.47 10.92
−0.07 −0.18 −0.04 −0.16 −0.05 −6.02 −0.15 −0.23 −0.27 −0.19
Financing
−0.09 −0.12 −0.11 −0.13 −0.21 5.11 −0.86 −0.84 −0.84 −0.77
−0.11 −0.13 −0.13 −0.15 −0.18 0.00 −0.10 0.00 −0.50 −0.75

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.